Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of “Hold” from Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has been assigned an average recommendation of “Hold” from the twenty ratings firms that are covering the company, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $12.31.

A number of equities analysts have recently commented on the stock. Truist Financial cut their price target on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Stifel Nicolaus dropped their target price on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Finally, Jefferies Financial Group boosted their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a report on Tuesday, September 17th.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $9.18 on Tuesday. The firm has a market cap of $1.57 billion, a PE ratio of -6.51 and a beta of 0.90. The firm’s fifty day moving average is $7.93 and its 200-day moving average is $10.58. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. Sell-side analysts predict that Teladoc Health will post -1.18 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, Director Thomas Mckinley bought 4,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares in the company, valued at approximately $300,502.13. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, COO Michael Willem Waters sold 6,053 shares of the business’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the sale, the chief operating officer now directly owns 74,214 shares of the company’s stock, valued at $604,101.96. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Thomas Mckinley bought 4,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the transaction, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. The disclosure for this purchase can be found here. Insiders sold a total of 57,377 shares of company stock valued at $438,054 over the last three months. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC purchased a new position in Teladoc Health in the fourth quarter valued at about $28,000. Signaturefd LLC lifted its stake in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at approximately $29,000. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at approximately $46,000. Finally, SageView Advisory Group LLC purchased a new stake in shares of Teladoc Health during the 1st quarter valued at approximately $48,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.